| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
2-4-3 Foundation |
501 SILVERSIDE RD STE 123 WILMINGTON,DE19809 |
2022-10-04 | 18,036,292 | capital endowment | 160,477 | NO | 5/10/2024 | none necessary | |
|
2-4-3 Foundation |
501 SILVERSIDE RD STE 123 WILMINGTON,DE19809 |
2023-02-03 | 2,561,088 | capital endowment | NO | EXPECTED IN 2024 | none necessary | ||
|
2-4-3 Foundation |
501 SILVERSIDE RD STE 123 WILMINGTON,DE19809 |
2023-04-28 | 505,618 | capital endowment | NO | EXPECTED IN 2024 | none necessary | ||
|
2-4-3 Foundation |
501 SILVERSIDE RD STE 123 WILMINGTON,DE19809 |
2023-08-01 | 433,252 | capital endowment | NO | EXPECTED IN 2024 | none necessary | ||
|
2-4-3 Foundation |
501 SILVERSIDE RD STE 123 WILMINGTON,DE19809 |
2023-10-27 | 387,155 | capital endowment | NO | EXPECTED IN 2024 | none necessary |
| Identifier | Return Reference | Explanation |
|---|---|---|
| FORM 990-PF, PARTS I AND XIV | FORM 990-PF, PARTS I AND XIV: | TOTAL Part I, Line 25, Column (a) and Part XIV, Line 3a: $3,887,113 Less amount not treated as qualifying distribution: $2,900,113 TOTAL Part I, Line 25, Column (d): $987,000 |
| FORM 8865 | FORM 8865 | The Foundation has prepared this form to the best of its ability based on the limited information provided to it by the investment on which the Foundation is reporting and on the basis of having received no information to the contrary. Any missing or incomplete information is due to the Foundation's inability to obtain such information and is not a willful attempt to withhold such information. |
| FORM 926 | FORM 926 | The Foundation has prepared these forms to the best of its ability based on the limited information provided to it by the investment on which the Foundation is reporting and on the basis of having received no information to the contrary. Any missing or incomplete information is due to the Foundation's inability to obtain such information and is not a willful attempt to withhold such information. |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ARTISAN GLOBAL OPPORTUNITIES F | 750,052 | 638,584 |
| ARTISAN THEMATIC FUND CL ADVIS | 739,373 | 655,311 |
| WISDOMTREE FLOATING RATE TREAS | 7,437,984 | 7,427,571 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| CASDIN PARTNERS OFFSHORE, LTD | 2,000,000 | 871,131 | |
| CVI CREDIT VALUE FUND B V LP | 1,184,878 | 1,172,980 | |
| IRRADIANT CLO PARTNERS FUND II | 3,124,354 | 2,988,079 | |
| MONARCH CAPITAL PTNS OFFSHORE | 398,899 | 524,568 | |
| RA CAPITAL HEALTHCARE INTERNAT | 5,000,000 | 4,190,624 | |
| AUDAX SENIOR LOAN FUND I OFFSH | 3,634,818 | 4,276,504 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 20,000 | 20,000 | ||
| K-1 Exp CVI CREDIT VALUE FUND | 1,739 | 1,739 | ||
| K-1 Exp IRRADIANT CLO PARTNERS | 45,918 | 45,918 | ||
| State or Local Filing Fees | 25 | 25 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| K-1 Inc/Loss CVI CREDIT VALUE FUND B V LP | 85,163 | 85,163 | |
| K-1 Inc/Loss IRRADIANT CLO PARTNERS FUND II, LP | 657,700 | 657,700 | |
| Interest Income from Notes | 75,940 | 75,940 | |
| PFIC INCOME - AUDAX SENIOR FUND LOAN | 403,348 | 403,348 |
| Borrower's Name | Relationship to Insider | Original Amount of Loan | Balance Due | Date of Note | Maturity Date | Repayment Terms | Interest Rate | Security Provided by Borrower | Purpose of Loan | Description of Lender Consideration | Consideration FMV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROMISSORY NOTE - LEGACY PHARMA - 27 | 1,510,000 | 1,510,000 | 2023-10 | 2027-10 | INTEREST QTLY/PRINCIPAL ON MATURITY | 27 % | NONE | INVESTMENT | CASH 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Management Services | 82,599 | 82,599 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2023 | 4,200 |